Ozempic is becoming popular among diabetics and people who want to lose weight. But it has a few side effects, including ...

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

The popularity of weight loss drugs has caused a shortage in recent years, but how effective are they at helping with food ...

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic ... zanubrutinib until disease progression or unacceptable ...

AstraZeneca has licensed in an antisense drug from Ionis Pharmaceuticals to treat kidney disease in a deal worth ... Biogen resulted in development and approval of Spinraza (nusinersen), approved ...